Expensive Cancer Drugs From Gilead and Novartis Losing Patients to Experimental Treatments
Large numbers of U.S. lymphoma patients are opting into experimental treatments in clinical trials versus expensive cell therapies sold by Gilead and Novartis, new...
$3+ Billion Revenue TRUVADA and the Interesting Patent Question Few Knew About
The price of drugs becomes more contentious as some classes of drugs increase in price far faster than prevailing incomes. This overall trend appears...
ICER Analysis Points out Novartis Mayzent Too High
ICER found that tiprotimod (Mayzent) reduced the risk of multiple sclerosis progression as well as decreased inflammatory disease activities however it’s analysis reveals the...
FDA Approves Pfizer’s Biosimilar, Zirabev, to Roche’s Avastin
The FDA has approved bevacizumab-bvxr (Zirabev, Pfizer), a biosimilar to bevacizumab (Avastin, Genentech/Roche), for the treatment of five types of cancer. These cancers include...
Does ICER Promote Discriminatory Drug Pricing Based on Its Analytics Methods?
A nonprofit known as Alliance for Aging Research has put out a fact sheet suggesting ICER research analytics be questioned on grounds that it...
WHO: Pricing of Cancer Medicines and It’s Impacts
WHO, a World Health Organization that examines pricing approaches adopted by the pharmaceutical industry and authorities responsible for the pricing of medicines, has a...
Should the United States Adopt Germany’s Model of Negotiating Drug Prices?
Germany’s approach to negotiating drug prices demonstrates that a balanced result can be achieved when patients don’t lose drug access or choice options and...
ICER Final Report on Spravato Puts in the ‘Low Value for Money’ Category for...
Janssen (J&J) Esketamine recently was approved as an antidepressant by the FDA. Called Spravato, the original cat tranquilizer was used for off-label treatment of...
Why do 11 Cancer Centers Get to Charge More than Other Elite Hospitals and...
Eleven cancer centers have been allowed by the U.S government to charge higher fees for their care than other centers. A new study identifies...
- Advertisement -